Reported positions
Quarter-end holdings as filed
Explore the full published position list and its source filing. This record excludes the manager’s cash, shorts and non-13(f) assets.
EVENTIDE ASSET MANAGEMENT, LLC
A quarter-end snapshot. Filed up to 45 days later, so this page is not current holdings and never a complete portfolio. what a 13F is — and is not ↓ · methodology §13F ↗
Period
$6.0B
reported valuesum of disclosed values for 2026-03-31; 0 positions carry a NULL value and are excluded from the sum, surfaced here rather than folded away
278
positionsALL retained default holdings for this (filer, period), including NULL-value ones
46
new stakespositions with no comparable holding in the prior quarter (kind new), 2026-03-31
36
exitspositions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record
Position changes — into 2026-03-31
by shares · Δ value · filing link · how changes are classified §Positionposition matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match identity_reconciled_by_cusip | Changethe reported share count is unchanged across the pair, so the position reads as held rather than as a buy or a sell; only builds before this release inferred a direction from the reported value instead classified_by_value · "exit" = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · "no change" = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an add or a trim (Add / New / Trim / Exit / No change) · "no prior" = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake | Δ valuederived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero | Δ shares | Prev value | Curr value | Prev shares | Curr shares | Flags |
|---|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INC COMposition key pos:18541 · issuer key iss:1057 | trim | −$38.4M | −148,712 | $256M | $218M | 2,511,091 | 2,362,379 | |
TRANE TECHNOLOGIES PLC SHSposition key pos:14960 · issuer key iss:2639 | add | +$12.0M | +3,281 | $157M | $169M | 403,274 | 406,555 | |
LAM RESEARCH CORP COM NEWposition key pos:11298 · issuer key iss:1321 | add | +$31.9M | +19,313 | $115M | $147M | 669,089 | 688,402 | |
MIRUM PHARMACEUTICALS INC COMposition key pos:12357 · issuer key iss:1485 | trim | −$35.3M | −684,711 | $165M | $130M | 2,093,582 | 1,408,871 | |
TARGA RES CORP COMposition key pos:14766 · issuer key iss:2090 | add | +$37.1M | +21,737 | $88.7M | $126M | 480,550 | 502,287 | |
XOMETRY INC CLASS A COMposition key sid:sec:prov:e2e110d836d8ffc2e5f76e7fa0612596 · issuer key cusip6:98423F | add | −$53.9M | +24,113 | $175M | $121M | 2,936,126 | 2,960,239 | |
GE VERNOVA INC COMposition key pos:18297 · issuer key iss:993 | trim | −$6.8M | −53,922 | $122M | $116M | 187,122 | 133,200 | |
OLD DOMINION FREIGHT LINE IN COMposition key pos:11269 · issuer key iss:1612 | trim | +$19.7M | −18,953 | $95.8M | $115M | 610,644 | 591,691 | |
SCHOLAR ROCK HLDG CORP COMposition key pos:18628 · issuer key iss:1936 | trim | +$827K | −233,948 | $107M | $108M | 2,431,333 | 2,197,385 | |
ARGENX SE SPONSORED ADRposition key pos:18170 · issuer key iss:242 | add | −$10.2M | +4,436 | $102M | $91.7M | 121,221 | 125,657 | |
ASML HLDG NV N Y REGISTRY SHSposition key pos:12478 · issuer key iss:2693 | add | +$18.4M | +1,290 | $71.5M | $89.9M | 66,820 | 68,110 | |
IRHYTHM HOLDINGS INC COMposition key pos:13207 · issuer key iss:1153 | add | −$33.1M | +68,339 | $123M | $89.8M | 692,486 | 760,825 | |
INSMED INC COM PAR $.01position key pos:15087 · issuer key iss:1181 | add | +$5.1M | +62,721 | $84.2M | $89.3M | 483,589 | 546,310 | |
AXSOME THERAPEUTICS INC. COMposition key pos:13938 · issuer key iss:295 | trim | −$16.4M | −51,668 | $104M | $87.8M | 571,226 | 519,558 | |
VAXCYTE INC COMposition key pos:12513 · issuer key iss:2248 | add | +$37.5M | +457,177 | $42.3M | $79.8M | 917,115 | 1,374,292 | |
ENTERGY CORP NEW COMposition key pos:12907 · issuer key iss:830 | add | +$14.2M | +9,765 | $62.3M | $76.5M | 673,082 | 682,847 | |
VISTRA CORP COMposition key pos:12068 · issuer key iss:2283 | add | −$4.7M | +5,075 | $78.7M | $74.0M | 487,636 | 492,711 | |
UNITED RENTALS INC COMposition key pos:17186 · issuer key iss:2208 | add | −$6.5M | +1,855 | $77.7M | $71.2M | 95,940 | 97,795 | |
LIBERTY ENERGY INC COM CL Aposition key pos:18921 · issuer key iss:1347 | add | +$32.8M | +432,639 | $36.4M | $69.2M | 1,970,459 | 2,403,098 | |
TOAST INC CL Aposition key pos:11997 · issuer key iss:2141 | add | −$22.3M | +2,629 | $88.3M | $66.0M | 2,486,040 | 2,488,669 | |
METTLER TOLEDO INTERNATIONAL COMposition key pos:18754 · issuer key iss:1471 | add | −$6.2M | +493 | $70.1M | $64.0M | 50,258 | 50,751 | |
MONOLITHIC PWR SYS INC COMposition key pos:15750 · issuer key iss:1498 | trim | +$1.4M | −10,219 | $62.0M | $63.4M | 68,373 | 58,154 | |
ROYALTY PHARMA PLC SHS CLASS Aposition key pos:18949 · issuer key iss:2606 | add | +$12.4M | +15,708 | $50.2M | $62.6M | 1,296,826 | 1,312,534 | |
NVENT ELEC PLC SHSposition key pos:13754 · issuer key iss:2582 | add | +$9.1M | +8,667 | $52.6M | $61.6M | 514,890 | 523,557 | |
WILLIAMS COS INC COMposition key pos:16453 · issuer key iss:2336 | add | +$12.8M | +39,088 | $47.7M | $60.5M | 793,160 | 832,248 | |
NASDAQ INC COMposition key pos:13365 · issuer key iss:1528 | add | −$8.6M | +4,791 | $68.8M | $60.2M | 707,048 | 711,839 | |
GENERAC HLDGS INC COMposition key pos:13771 · issuer key iss:995 | add | +$47.1M | +212,978 | $12.8M | $59.9M | 93,860 | 306,838 | |
BETA BIONICS INC COMposition key sid:sec:prov:4e7eb09ab13c64fd6730ede8dbc988b8 · issuer key cusip6:08659B | add | −$92.7M | +950,760 | $152M | $59.6M | 4,994,728 | 5,945,488 | |
D R HORTON INC COMposition key pos:15301 · issuer key iss:702 | add | −$2.5M | +3,826 | $61.5M | $59.0M | 427,045 | 430,871 | |
KLA CORP COM NEWposition key pos:19106 · issuer key iss:1265 | trim | +$2.5M | −5,643 | $55.2M | $57.8M | 45,282 | 39,639 | |
BELITE BIO INC SPONSORED ADSposition key sid:sec:prov:831c753eb8a6ce9972092ec4165601d4 · issuer key cusip6:07782B | trim | −$4.3M | −25,441 | $61.3M | $57.0M | 383,091 | 357,650 | |
LATTICE SEMICONDUCTOR CORP COMposition key pos:16871 · issuer key iss:1329 | trim | +$10.9M | −10,018 | $45.7M | $56.6M | 621,156 | 611,138 | |
PROLOGIS INC. COMposition key pos:17094 · issuer key iss:1767 | add | +$2.2M | +6,299 | $53.9M | $56.1M | 420,834 | 427,133 | |
TRANSMEDICS GROUP INC COMposition key pos:18593 · issuer key iss:2152 | add | −$12.2M | +557 | $66.7M | $54.5M | 548,267 | 548,824 | |
DT MIDSTREAM INC COMMON STOCKposition key pos:13094 · issuer key iss:704 | add | +$6.9M | +7,227 | $47.3M | $54.1M | 394,724 | 401,951 | |
NISOURCE INC COMposition key pos:12987 · issuer key iss:1573 | add | +$6.0M | +10,370 | $47.3M | $53.3M | 1,133,220 | 1,143,590 | |
KYMERA THERAPEUTICS INC COMposition key pos:13465 · issuer key iss:1310 | add | +$3.5M | +495 | $48.7M | $52.2M | 626,430 | 626,925 | |
RB GLOBAL INC COMposition key pos:18741 · issuer key iss:1794 | add | −$3.7M | +548 | $54.3M | $50.6M | 527,595 | 528,143 | |
WASTE CONNECTIONS INC COMposition key pos:17711 · issuer key iss:2306 | trim | −$4.0M | −184 | $54.4M | $50.3M | 310,111 | 309,927 | |
OREILLY AUTOMOTIVE INC COMposition key pos:12254 · issuer key iss:1601 | trim | +$401K | −1,987 | $49.4M | $49.8M | 541,867 | 539,880 | |
QUANTA SVCS INC COMposition key pos:14199 · issuer key iss:1790 | add | +$11.4M | +454 | $37.6M | $49.0M | 88,932 | 89,386 | |
COLLEGIUM PHARMACEUTICAL INC COMposition key pos:18501 · issuer key iss:619 | trim | −$39.8M | −451,957 | $86.9M | $47.1M | 1,876,239 | 1,424,282 | |
APOGEE THERAPEUTICS INC COMposition key pos:14112 · issuer key iss:217 | add | +$14.0M | +121,408 | $32.9M | $46.9M | 436,015 | 557,423 | |
VULCAN MATLS CO COMposition key pos:13001 · issuer key iss:2292 | add | −$2.2M | +205 | $48.3M | $46.2M | 169,367 | 169,572 | |
NVIDIA CORPORATION COMposition key pos:16535 · issuer key iss:1593 | add | −$28.1K | +20,135 | $44.7M | $44.7M | 239,284 | 259,419 | |
EASTGROUP PPTYS INC COMposition key pos:13638 · issuer key iss:788 | trim | +$1.5M | −428 | $42.1M | $43.6M | 236,158 | 235,730 | |
STERIS PLC SHS USDposition key pos:14120 · issuer key iss:2627 | add | −$5.3M | +4,152 | $48.3M | $43.0M | 190,483 | 194,635 | |
PALO ALTO NETWORKS INC COMposition key pos:15667 · issuer key iss:1670 | add | +$13.5M | +106,260 | $26.9M | $40.4M | 145,891 | 252,151 | |
LOWES COS INC COMposition key pos:17070 · issuer key iss:1374 | add | −$987K | +7 | $41.2M | $40.2M | 170,628 | 170,635 | |
ROLLINS INC COMposition key pos:12799 · issuer key iss:1866 | add | −$4.2M | +13,753 | $44.4M | $40.2M | 739,746 | 753,499 | |
ELEMENT SOLUTIONS INC COMposition key pos:19038 · issuer key iss:805 | add | +$11.0M | +22,321 | $28.7M | $39.8M | 1,149,146 | 1,171,467 | |
FERGUSON ENTERPRISES INC COMMON STOCK NEWposition key pos:18814 · issuer key iss:904 | add | +$1.8M | +1,185 | $37.5M | $39.3M | 168,275 | 169,460 | |
HUNTINGTON BANCSHARES INC COMposition key pos:18776 · issuer key iss:1138 | trim | −$4.9M | −7,159 | $44.2M | $39.3M | 2,540,661 | 2,533,502 | |
CHEWY INC CL Aposition key pos:17362 · issuer key iss:573 | trim | −$8.6M | −427 | $46.7M | $38.1M | 1,412,717 | 1,412,290 | |
TERADYNE INC COMposition key pos:16218 · issuer key iss:2113 | add | +$30.1M | +88,834 | $7.5M | $37.6M | 38,632 | 127,466 | |
GLOBAL E ONLINE LTD SHSposition key pos:13076 · issuer key iss:2682 | add | −$10.3M | +656 | $47.9M | $37.6M | 1,217,689 | 1,218,345 | |
TALEN ENERGY CORP COMposition key pos:16855 · issuer key iss:2082 | trim | −$9.4M | −7,413 | $46.7M | $37.4M | 124,596 | 117,183 | |
FASTENAL CO COMposition key pos:16201 · issuer key iss:898 | add | +$5.6M | +19,919 | $31.3M | $36.9M | 777,666 | 797,585 | |
ABIVAX SA SPONSORED ADSposition key pos:13227 · issuer key iss:50 | trim | −$8.5M | −7,335 | $44.2M | $35.7M | 327,911 | 320,576 | |
ROPER TECHNOLOGIES INC COMposition key pos:11035 · issuer key iss:1869 | trim | −$48.2M | −88,505 | $82.0M | $33.8M | 184,166 | 95,661 | |
HOULIHAN LOKEY INC CL Aposition key pos:15861 · issuer key iss:1127 | add | −$7.0M | +1,732 | $40.9M | $33.8M | 234,404 | 236,136 | |
CELLDEX THERAPEUTICS INC NEW COM NEWposition key sid:sec:prov:30f8f229420c7a82ec2ecf2f2f622045 · issuer key cusip6:15117B | trim | −$11.7M | −605,559 | $44.6M | $32.9M | 1,642,559 | 1,037,000 | |
BRIDGEBIO PHARMA INC COMposition key pos:15468 · issuer key iss:427 | add | +$4.8M | +75,000 | $27.7M | $32.5M | 362,130 | 437,130 | |
APPLIED INDL TECHNOLOGIES IN COMposition key pos:18323 · issuer key iss:225 | add | +$1.4M | +1,952 | $30.7M | $32.1M | 119,335 | 121,287 | |
CYTOKINETICS INC COM NEWposition key pos:13331 · issuer key iss:700 | trim | +$1.1M | −513 | $30.5M | $31.6M | 479,611 | 479,098 | |
DEXCOM INC COMposition key pos:15920 · issuer key iss:727 | add | −$399K | +20,693 | $31.5M | $31.1M | 474,310 | 495,003 | |
AXON ENTERPRISE INC COMposition key pos:13603 · issuer key iss:294 | trim | −$10.5M | −859 | $40.2M | $29.6M | 70,702 | 69,843 | |
GENEDX HOLDINGS CORP COM CL Aposition key pos:11515 · issuer key iss:1951 | new | +$29.5M | +459,015 | $0 | $29.5M | — | 459,015 | |
PALVELLA THERAPEUTICS INC NE COMposition key sid:sec:prov:306a1219dc3e80453ba2cb392e4281b0 · issuer key cusip6:697947 | add | +$18.4M | +131,500 | $10.6M | $29.0M | 101,748 | 233,248 | |
KESTRA MED TECHNOLOGIES LTD SHSposition key sid:sec:prov:369e1c5681e056c6b774b8d85dbdd346 · issuer key cusip6:G52441 | add | −$4.9M | +176,213 | $33.7M | $28.8M | 1,269,651 | 1,445,864 | |
DATADOG INC CL A COMposition key pos:17430 · issuer key iss:713 | add | −$4.2M | +919 | $32.5M | $28.3M | 238,916 | 239,835 | |
CELCUITY INC COMposition key pos:11232 · issuer key iss:542 | trim | −$3.5M | −69,780 | $31.3M | $27.8M | 313,679 | 243,899 | |
EVOMMUNE INC COM SHSposition key sid:sec:prov:adbff6ad799c41f5a1fe4cddc6ffc42b · issuer key cusip6:30054Y | add | +$11.3M | +247,604 | $16.5M | $27.8M | 961,525 | 1,209,129 | |
INTUITIVE SURGICAL INC COM NEWposition key pos:17712 · issuer key iss:1213 | add | −$6.0M | +551 | $33.7M | $27.6M | 59,391 | 59,942 | |
MSCI INC COMposition key pos:16902 · issuer key iss:1398 | add | +$6.6M | +14,788 | $20.9M | $27.5M | 36,280 | 51,068 | |
BAKER HUGHES COMPANY CL Aposition key pos:11510 · issuer key iss:309 | add | +$10.7M | +88,043 | $16.0M | $26.7M | 349,974 | 438,017 | |
CENTESSA PHARMACEUTICALS PLC SPONSORED ADSposition key pos:18882 · issuer key cusip6:152309 | new | +$26.5M | +668,142 | $0 | $26.5M | — | 668,142 | |
SIONNA THERAPEUTICS INC COMposition key pos:11054 · issuer key iss:1980 | add | −$414K | +6,485 | $26.3M | $25.9M | 639,045 | 645,530 | |
FRONTDOOR INC COMposition key pos:12980 · issuer key iss:967 | add | −$2.3M | +1,071 | $28.0M | $25.7M | 485,161 | 486,232 | |
EQT CORP COMposition key pos:13443 · issuer key iss:781 | trim | +$3.5M | −9,632 | $22.0M | $25.5M | 409,607 | 399,975 | |
SITIME CORP COMposition key pos:13075 · issuer key iss:1983 | trim | −$29.7M | −82,318 | $55.1M | $25.4M | 155,983 | 73,665 | |
REVOLUTION MEDICINES INC COMposition key pos:15541 · issuer key iss:1842 | trim | −$4.7M | −116,836 | $30.1M | $25.4M | 378,261 | 261,425 | |
DISC MEDICINE INC COMposition key pos:13022 · issuer key iss:741 | add | −$6.1M | +180 | $31.4M | $25.3M | 395,392 | 395,572 | |
CG ONCOLOGY INC COMposition key pos:12402 · issuer key iss:558 | add | +$12.1M | +57,540 | $13.0M | $25.0M | 312,445 | 369,985 | |
WEC ENERGY GROUP INC COMposition key pos:16233 · issuer key iss:2297 | add | +$2.4M | +2,355 | $21.8M | $24.2M | 206,717 | 209,072 | |
VERTIV HOLDINGS CO COM CL Aposition key pos:17092 · issuer key iss:2266 | trim | +$6.6M | −10,989 | $17.2M | $23.8M | 105,999 | 95,010 | |
INTERNATIONAL PAPER CO COMposition key pos:18051 · issuer key iss:1204 | trim | −$5.7M | −80,782 | $28.7M | $23.0M | 726,220 | 645,438 | |
UL SOLUTIONS INC CLASS A COM SHSposition key pos:13132 · issuer key iss:2191 | new | +$22.8M | +267,774 | $0 | $22.8M | — | 267,774 | |
MOTOROLA SOLUTIONS INC COM NEWposition key pos:14260 · issuer key iss:1511 | trim | −$5.6M | −21,448 | $28.4M | $22.8M | 74,029 | 52,581 | |
SHERWIN WILLIAMS CO COMposition key pos:14643 · issuer key iss:1962 | add | −$139K | +520 | $22.9M | $22.8M | 70,604 | 71,124 | |
PENTAIR PLC SHSposition key pos:17360 · issuer key iss:2611 | trim | −$11.5M | −66,685 | $34.0M | $22.5M | 326,280 | 259,595 | |
HALLIBURTON CO COMposition key pos:11214 · issuer key iss:1074 | add | +$20.4M | +503,202 | $1.9M | $22.2M | 65,344 | 568,546 | |
CONSTELLATION ENERGY CORP COMposition key pos:17409 · issuer key iss:648 | add | −$4.1M | +4,072 | $26.2M | $22.1M | 74,036 | 78,108 | |
OVID THERAPEUTICS INC COMposition key sid:sec:prov:05937aba4ce92b128af1dbba8d10131b · issuer key cusip6:690469 | add | +$15.0M | +5,631,911 | $7.0M | $22.0M | 4,285,000 | 9,916,911 | |
ADC THERAPEUTICS SA SHSposition key sid:sec:prov:8da00f0cae7aab2e87fae6f0ec349fcf · issuer key cusip6:H0036K | add | +$9.5M | +2,337,588 | $11.9M | $21.4M | 3,364,067 | 5,701,655 | |
AMYLYX PHARMACEUTICALS INC COMposition key sid:sec:prov:6456a8a739b1b376bb8de72f440b1279 · issuer key cusip6:03237H | add | +$2.8M | +810 | $18.3M | $21.0M | 1,513,148 | 1,513,958 | |
HUBSPOT INC COMposition key pos:15184 · issuer key iss:1134 | trim | −$15.9M | −6,970 | $36.1M | $20.2M | 89,921 | 82,951 | |
ROCKWELL AUTOMATION INC COMposition key pos:11750 · issuer key iss:1861 | add | −$254K | +3,821 | $20.3M | $20.1M | 52,191 | 56,012 | |
IDEX CORP COMposition key pos:14332 · issuer key iss:1160 | add | +$1.4M | +1,758 | $17.7M | $19.1M | 99,135 | 100,893 | |
DIANTHUS THERAPEUTICS INC COMposition key pos:18462 · issuer key iss:731 | new | +$18.9M | +225,261 | $0 | $18.9M | — | 225,261 |
80 more changes below.
1–100 of 307 changes
Mark-to-market only (no share change) · 7
Positions whose share count is identical in both quarters; the value changed with price, not with a decision.
Positionposition matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match identity_reconciled_by_cusip | Changethe reported share count is unchanged across the pair, so the position reads as held rather than as a buy or a sell; only builds before this release inferred a direction from the reported value instead classified_by_value · "exit" = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · "no change" = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an add or a trim (Add / New / Trim / Exit / No change) · "no prior" = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake | Δ valuederived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero | Δ shares | Prev value | Curr value | Prev shares | Curr shares | Flags |
|---|---|---|---|---|---|---|---|---|
IONIS PHARMACEUTICALS INC COMposition key pos:12370 · issuer key iss:1221 | no change | −$2.3M | 0 | $45.5M | $43.2M | 575,000 | 575,000 | |
TREVI THERAPEUTICS INC COMposition key pos:18739 · issuer key iss:2160 | no change | −$1.5M | 0 | $32.8M | $31.3M | 2,622,306 | 2,622,306 | |
MBX BIOSCIENCES INC COMposition key sid:sec:prov:1910147dd0682cb840152de5838d5484 · issuer key cusip6:55287L | no change | −$1.5M | 0 | $28.1M | $26.6M | 890,000 | 890,000 | |
IMMIX BIOPHARMA INC COMposition key sid:sec:prov:a4c0ee8cb9f5ffef6a4d9929cac1aeee · issuer key cusip6:45258H | no change | +$9.9M | 0 | $13.3M | $23.2M | 2,549,019 | 2,549,019 | |
ARROWHEAD PHARMACEUTICALS IN COMposition key pos:16618 · issuer key iss:249 | no change | −$1.4M | 0 | $24.6M | $23.2M | 370,000 | 370,000 | |
NURIX THERAPEUTICS INC COMposition key sid:sec:prov:48ac0f50c981e01f7c5af17d58a117cf · issuer key cusip6:67080M | no change | −$4.5M | 0 | $24.6M | $20.1M | 1,297,893 | 1,297,893 | |
PRIVIA HEALTH GROUP INC COMposition key pos:15900 · issuer key iss:1760 | no change | −$2.3M | 0 | $17.5M | $15.2M | 737,694 | 737,694 |
Quarter ended 2026-03-31Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.
Changes derive from the aggregate's top-25 slices and keyable positions only; unkeyable holdings are counted in the registry, not differenced. methodology §13F ↗
Book shape
2026-03-31 · concentration · vs tracked median · tick = median- Top-25 concentration
- 40.5%below median 80.0%
- Concentration index
- 108 bpsbelow median 446 bps
- Positions with value
- 278 / 278median book 97.5 positions
Concentration uses reported 13F long value, not total assets. The index is withheld when any position lacks a value. Medians are over the 8,748 tracked filers with a 2026-03-31 book; the index median over the 8,662 with a complete book.
null-value positions: 0holdings whose <value> did not parse — retained and counted, never zero-filled · top-N share ·§: 40.5% · HHI (bps) ·§: 108integer Herfindahl–Hirschman index in basis points over disclosed position values · QoQ moves: 314
Filing history
AVAILABLE QUARTERS| Period | Source |
|---|---|
| 2026-03-31 | EDGAR ↗ |
PLANNED sector rotation · Congress overlap · signals for this filer
Complete source filings on SEC EDGAR
The complete filing on EDGAR.
The position list above is served from the published Public Filings build — every position this filer reported for the selected quarter, as it reported it. This block is provenance, not a substitute: the filing itself is the record, and it is one click away. Serving this list is M2-CONTRACT §3, amended 2026-08-02; §3.1 keeps live EDGAR for filings newer than this build.
Open EVENTIDE ASSET MANAGEMENT, LLC's 13F filings on SEC EDGAR ↗Notes on this data
Share changes
Compare consecutive quarters
Position changes retain the producer’s classification and comparability flags. Share counts and reported values describe different changes.
Coverage
A snapshot, not current holdings
Use the quarter selector to inspect available periods. Unknown values stay unknown and each table states its coverage.
ViewPrior quarter not yet availableThis build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.
Reported positions — 2026-03-31
1–100 of 278 positions · $6.0B disclosed value over 278 rows · 0 undisclosed-value rowsEvery row below carries ticker not yet mapped — stated once here rather than repeated on every row.
| KindClassification is not joined into this reported-position view. Use the changed-positions view to compare the two published quarters. | TickerThis list carries reported issuer names and security identities, without a dated ticker mapping. Symbols are not inferred from names. | Issuera position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filing | WeightShare of total reported value, calculated only when the full position list has disclosed values. This is 13F long value, not total assets. | Valuevalue undisclosed on the filing: retained and counted, excluded from sums, never shown as $0 | Shares | Position changeShare change is available in the separate comparison view; it is not joined into this position list. | Wt | CongressThe congressional transaction join is unavailable in this build. |
|---|---|---|---|---|---|---|---|---|
| — | GHverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GUARDANT HEALTH INC GUARDANT HEALTH INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $218M | 2,362,379 | — | 3.6% | — | |
| — | TTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TRANE TECHNOLOGIES PLC TRANE TECHNOLOGIES PLC · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $169M | 406,555 | — | 2.8% | — | |
| — | LRCXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | LAM RESEARCH CORP LAM RESEARCH CORP · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $147M | 688,402 | — | 2.4% | — | |
| — | MIRMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MIRUM PHARMACEUTICALS INC MIRUM PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $130M | 1,408,871 | — | 2.2% | — | |
| — | TRGPverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TARGA RES CORP TARGA RES CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $126M | 502,287 | — | 2.1% | — | |
| — | — | XOMETRY INC XOMETRY INC · CLASS A COM CUSIP 98423F109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $121M | 2,960,239 | — | 2.0% | — | |
| — | GEVverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GE VERNOVA INC GE VERNOVA INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $116M | 133,200 | — | 1.9% | — | |
| — | ODFLverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | OLD DOMINION FREIGHT LINE IN OLD DOMINION FREIGHT LINE IN · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $115M | 591,691 | — | 1.9% | — | |
| — | SRRKverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SCHOLAR ROCK HLDG CORP SCHOLAR ROCK HLDG CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $108M | 2,197,385 | — | 1.8% | — | |
| — | ARGXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ARGENX SE ARGENX SE · SPONSORED ADR CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $91.7M | 125,657 | — | 1.5% | — | |
| — | ASMLverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ASML HLDG NV ASML HLDG NV · N Y REGISTRY SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $89.9M | 68,110 | — | 1.5% | — | |
| — | IRTCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | IRHYTHM HOLDINGS INC IRHYTHM HOLDINGS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $89.8M | 760,825 | — | 1.5% | — | |
| — | INSMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INSMED INC INSMED INC · COM PAR $.01 CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $89.3M | 546,310 | — | 1.5% | — | |
| — | AXSMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | AXSOME THERAPEUTICS INC. AXSOME THERAPEUTICS INC. · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $87.8M | 519,558 | — | 1.5% | — | |
| — | PCVXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VAXCYTE INC VAXCYTE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $79.8M | 1,374,292 | — | 1.3% | — | |
| — | ETRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ENTERGY CORP NEW ENTERGY CORP NEW · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $76.5M | 682,847 | — | 1.3% | — | |
| — | VSTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VISTRA CORP VISTRA CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $74.0M | 492,711 | — | 1.2% | — | |
| — | URIverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | UNITED RENTALS INC UNITED RENTALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $71.2M | 97,795 | — | 1.2% | — | |
| — | LBRTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | LIBERTY ENERGY INC LIBERTY ENERGY INC · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $69.2M | 2,403,098 | — | 1.1% | — | |
| — | TOSTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TOAST INC TOAST INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $66.0M | 2,488,669 | — | 1.1% | — | |
| — | MTDverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | METTLER TOLEDO INTERNATIONAL METTLER TOLEDO INTERNATIONAL · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $64.0M | 50,751 | — | 1.1% | — | |
| — | MPWRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MONOLITHIC PWR SYS INC MONOLITHIC PWR SYS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $63.4M | 58,154 | — | 1.0% | — | |
| — | RPRXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ROYALTY PHARMA PLC ROYALTY PHARMA PLC · SHS CLASS A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $62.6M | 1,312,534 | — | 1.0% | — | |
| — | NVTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NVENT ELEC PLC NVENT ELEC PLC · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $61.6M | 523,557 | — | 1.0% | — | |
| — | WMBverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | WILLIAMS COS INC WILLIAMS COS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $60.5M | 832,248 | — | 1.0% | — | |
| — | NDAQverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NASDAQ INC NASDAQ INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $60.2M | 711,839 | — | 1.0% | — | |
| — | GNRCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GENERAC HLDGS INC GENERAC HLDGS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $59.9M | 306,838 | — | 1.0% | — | |
| — | — | BETA BIONICS INC BETA BIONICS INC · COM CUSIP 08659B102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $59.6M | 5,945,488 | — | 1.0% | — | |
| — | DHIverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | D R HORTON INC D R HORTON INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $59.0M | 430,871 | — | 1.0% | — | |
| — | KLACverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | KLA CORP KLA CORP · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $57.8M | 39,639 | — | 1.0% | — | |
| — | — | BELITE BIO INC BELITE BIO INC · SPONSORED ADS CUSIP 07782B104 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $57.0M | 357,650 | — | 0.9% | — | |
| — | LSCCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | LATTICE SEMICONDUCTOR CORP LATTICE SEMICONDUCTOR CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $56.6M | 611,138 | — | 0.9% | — | |
| — | PLDverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PROLOGIS INC. PROLOGIS INC. · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $56.1M | 427,133 | — | 0.9% | — | |
| — | TMDXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TRANSMEDICS GROUP INC TRANSMEDICS GROUP INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $54.5M | 548,824 | — | 0.9% | — | |
| — | DTMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DT MIDSTREAM INC DT MIDSTREAM INC · COMMON STOCK CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $54.1M | 401,951 | — | 0.9% | — | |
| — | NIverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NISOURCE INC NISOURCE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $53.3M | 1,143,590 | — | 0.9% | — | |
| — | KYMRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | KYMERA THERAPEUTICS INC KYMERA THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $52.2M | 626,925 | — | 0.9% | — | |
| — | RBAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | RB GLOBAL INC RB GLOBAL INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $50.6M | 528,143 | — | 0.8% | — | |
| — | WCNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | WASTE CONNECTIONS INC WASTE CONNECTIONS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $50.3M | 309,927 | — | 0.8% | — | |
| — | ORLYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | OREILLY AUTOMOTIVE INC OREILLY AUTOMOTIVE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $49.8M | 539,880 | — | 0.8% | — | |
| — | PWRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | QUANTA SVCS INC QUANTA SVCS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $49.0M | 89,386 | — | 0.8% | — | |
| — | COLLverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | COLLEGIUM PHARMACEUTICAL INC COLLEGIUM PHARMACEUTICAL INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $47.1M | 1,424,282 | — | 0.8% | — | |
| — | APGEverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | APOGEE THERAPEUTICS INC APOGEE THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $46.9M | 557,423 | — | 0.8% | — | |
| — | VMCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VULCAN MATLS CO VULCAN MATLS CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $46.2M | 169,572 | — | 0.8% | — | |
| — | NVDAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NVIDIA CORPORATION NVIDIA CORPORATION · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $44.7M | 259,419 | — | 0.7% | — | |
| — | EGPverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | EASTGROUP PPTYS INC EASTGROUP PPTYS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $43.6M | 235,730 | — | 0.7% | — | |
| — | IONSverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | IONIS PHARMACEUTICALS INC IONIS PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $43.2M | 575,000 | — | 0.7% | — | |
| — | STEverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | STERIS PLC STERIS PLC · SHS USD CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $43.0M | 194,635 | — | 0.7% | — | |
| — | PANWverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PALO ALTO NETWORKS INC PALO ALTO NETWORKS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $40.4M | 252,151 | — | 0.7% | — | |
| — | LOWverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | LOWES COS INC LOWES COS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $40.2M | 170,635 | — | 0.7% | — | |
| — | ROLverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ROLLINS INC ROLLINS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $40.2M | 753,499 | — | 0.7% | — | |
| — | ESIverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ELEMENT SOLUTIONS INC ELEMENT SOLUTIONS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $39.8M | 1,171,467 | — | 0.7% | — | |
| — | FERGverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | FERGUSON ENTERPRISES INC FERGUSON ENTERPRISES INC · COMMON STOCK NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $39.3M | 169,460 | — | 0.7% | — | |
| — | HBANverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | HUNTINGTON BANCSHARES INC HUNTINGTON BANCSHARES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $39.3M | 2,533,502 | — | 0.6% | — | |
| — | CHWYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CHEWY INC CHEWY INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $38.1M | 1,412,290 | — | 0.6% | — | |
| — | TERverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TERADYNE INC TERADYNE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $37.6M | 127,466 | — | 0.6% | — | |
| — | GLBEverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GLOBAL E ONLINE LTD GLOBAL E ONLINE LTD · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $37.6M | 1,218,345 | — | 0.6% | — | |
| — | TLNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TALEN ENERGY CORP TALEN ENERGY CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $37.4M | 117,183 | — | 0.6% | — | |
| — | FASTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | FASTENAL CO FASTENAL CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $36.9M | 797,585 | — | 0.6% | — | |
| — | ABVXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ABIVAX SA ABIVAX SA · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $35.7M | 320,576 | — | 0.6% | — | |
| — | ROPverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ROPER TECHNOLOGIES INC ROPER TECHNOLOGIES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $33.8M | 95,661 | — | 0.6% | — | |
| — | HLIverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | HOULIHAN LOKEY INC HOULIHAN LOKEY INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $33.8M | 236,136 | — | 0.6% | — | |
| — | — | CELLDEX THERAPEUTICS INC NEW CELLDEX THERAPEUTICS INC NEW · COM NEW CUSIP 15117B202 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $32.9M | 1,037,000 | — | 0.5% | — | |
| — | BBIOverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $32.5M | 437,130 | — | 0.5% | — | |
| — | AITverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | APPLIED INDL TECHNOLOGIES IN APPLIED INDL TECHNOLOGIES IN · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $32.1M | 121,287 | — | 0.5% | — | |
| — | CYTKverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CYTOKINETICS INC CYTOKINETICS INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $31.6M | 479,098 | — | 0.5% | — | |
| — | TRVIverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TREVI THERAPEUTICS INC TREVI THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $31.3M | 2,622,306 | — | 0.5% | — | |
| — | DXCMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DEXCOM INC DEXCOM INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $31.1M | 495,003 | — | 0.5% | — | |
| — | AXONverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | AXON ENTERPRISE INC AXON ENTERPRISE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $29.6M | 69,843 | — | 0.5% | — | |
| — | WGSverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GENEDX HOLDINGS CORP GENEDX HOLDINGS CORP · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $29.5M | 459,015 | — | 0.5% | — | |
| — | — | PALVELLA THERAPEUTICS INC NE PALVELLA THERAPEUTICS INC NE · COM CUSIP 697947109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $29.0M | 233,248 | — | 0.5% | — | |
| — | — | KESTRA MED TECHNOLOGIES LTD KESTRA MED TECHNOLOGIES LTD · SHS CUSIP G52441105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $28.8M | 1,445,864 | — | 0.5% | — | |
| — | DDOGverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DATADOG INC DATADOG INC · CL A COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $28.3M | 239,835 | — | 0.5% | — | |
| — | CELCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CELCUITY INC CELCUITY INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $27.8M | 243,899 | — | 0.5% | — | |
| — | — | EVOMMUNE INC EVOMMUNE INC · COM SHS CUSIP 30054Y107 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $27.8M | 1,209,129 | — | 0.5% | — | |
| — | ISRGverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INTUITIVE SURGICAL INC INTUITIVE SURGICAL INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $27.6M | 59,942 | — | 0.5% | — | |
| — | MSCIverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MSCI INC MSCI INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $27.5M | 51,068 | — | 0.5% | — | |
| — | BKRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BAKER HUGHES COMPANY BAKER HUGHES COMPANY · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $26.7M | 438,017 | — | 0.4% | — | |
| — | — | MBX BIOSCIENCES INC MBX BIOSCIENCES INC · COM CUSIP 55287L101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $26.6M | 890,000 | — | 0.4% | — | |
| — | — | CENTESSA PHARMACEUTICALS PLC CENTESSA PHARMACEUTICALS PLC · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $26.5M | 668,142 | — | 0.4% | — | |
| — | SIONverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SIONNA THERAPEUTICS INC SIONNA THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.9M | 645,530 | — | 0.4% | — | |
| — | FTDRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | FRONTDOOR INC FRONTDOOR INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.7M | 486,232 | — | 0.4% | — | |
| — | EQTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | EQT CORP EQT CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.5M | 399,975 | — | 0.4% | — | |
| — | SITMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SITIME CORP SITIME CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.4M | 73,665 | — | 0.4% | — | |
| — | RVMDverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | REVOLUTION MEDICINES INC REVOLUTION MEDICINES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.4M | 261,425 | — | 0.4% | — | |
| — | IRONverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DISC MEDICINE INC DISC MEDICINE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.3M | 395,572 | — | 0.4% | — | |
| — | CGONverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CG ONCOLOGY INC CG ONCOLOGY INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.0M | 369,985 | — | 0.4% | — | |
| — | WECverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | WEC ENERGY GROUP INC WEC ENERGY GROUP INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $24.2M | 209,072 | — | 0.4% | — | |
| — | VRTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VERTIV HOLDINGS CO VERTIV HOLDINGS CO · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $23.8M | 95,010 | — | 0.4% | — | |
| — | — | IMMIX BIOPHARMA INC IMMIX BIOPHARMA INC · COM CUSIP 45258H106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $23.2M | 2,549,019 | — | 0.4% | — | |
| — | ARWRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ARROWHEAD PHARMACEUTICALS IN ARROWHEAD PHARMACEUTICALS IN · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $23.2M | 370,000 | — | 0.4% | — | |
| — | IPverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INTERNATIONAL PAPER CO INTERNATIONAL PAPER CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $23.0M | 645,438 | — | 0.4% | — | |
| — | ULSverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | UL SOLUTIONS INC UL SOLUTIONS INC · CLASS A COM SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $22.8M | 267,774 | — | 0.4% | — | |
| — | MSIverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MOTOROLA SOLUTIONS INC MOTOROLA SOLUTIONS INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $22.8M | 52,581 | — | 0.4% | — | |
| — | SHWverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SHERWIN WILLIAMS CO SHERWIN WILLIAMS CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $22.8M | 71,124 | — | 0.4% | — | |
| — | PNRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PENTAIR PLC PENTAIR PLC · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $22.5M | 259,595 | — | 0.4% | — | |
| — | HALverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | HALLIBURTON CO HALLIBURTON CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $22.2M | 568,546 | — | 0.4% | — | |
| — | CEGverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CONSTELLATION ENERGY CORP CONSTELLATION ENERGY CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $22.1M | 78,108 | — | 0.4% | — | |
| — | — | OVID THERAPEUTICS INC OVID THERAPEUTICS INC · COM CUSIP 690469101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $22.0M | 9,916,911 | — | 0.4% | — | |
| — | — | ADC THERAPEUTICS SA ADC THERAPEUTICS SA · SHS CUSIP H0036K147 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $21.4M | 5,701,655 | — | 0.4% | — |
1–100 of 278 positions · page 1 of 3
every row this filer reported for the quarter, as it reported it — cross-filer de-duplication is applied to issuer totals elsewhere and never deletes a row here
A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗
13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.
Positions are quarter-end snapshots filed up to 45 days late — not current holdings. A position may have been changed or closed before you ever see it, and is older still by however long ago that quarter ended.
Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars with unit_basis carried on every record.
Affiliated managers may report the same position (otherManager), so one position can appear under more than one filer.
Positions under confidential treatment may be omitted until a later amendment discloses them.
These are disclosures, not investment advice (ARCHITECTURE.md §5.2 / M2-CONTRACT §5).